Endoscopic Treatment for Local Residual Neoplasia

Vitkovice Hospital

Status: Completed

Conditions: Colorectal Cancer

Treatments: Procedure: Standardized endoscopic treatment of local residual neoplasia

Study type: Interventional

Funder types: Other

Identifiers

NCT02386618

DDC VN 07

Details and patient eligibility

About

Endoscopic mucosal resection (EMR) is considered to be a gold standard of therapy of colorectal lateral spreading tumors (LST) without significant risk for lymphatic spread. According to the investigators previous study, local residual neoplasia (LRN) after conventional endoscopic mucosal resection (EMR)occurs in up to 21% of cases. Endoscopic therapy of LRN was not sufficient in 53 % and has not been standardized yet.

Enrollment: 25 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients older than 18 years
• patients with local residual neoplasia in scar in three months after endoscopic mucosal resection for laterally spreading tumor (0-IIa > 10 mm)
• signed informed consent

Exclusion criteria

• incomplete endoscopic mucosal resection
• previous therapy for local residual neoplasia
• difficult or impossible localization of post-EMR scar

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

Local residual neoplasia

Other group

Description:

Patients with local residual neoplasia in 3 months after endoscopic resection of colorectal lateral spreading tumors diagnosed endoscopically and/or histologically

Treatment:

Procedure: Standardized endoscopic treatment of local residual neoplasia